Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2004 08:07 ET | Source: Galapagos Genomics

Galapagos announces the separation of its drug discovery and target discovery service -- forms Galadeno(TM) as an independent business unit

MECHELEN, Belgium, Sept. 22, 2004 (PRIMEZONE) -- Galapagos Genomics NV, Europe's leading target discovery company, announced today that it has created a new business unit for its viral based...
June 07, 2004 02:07 ET | Source: Galapagos Genomics

Galapagos Reports Success in Identification and Validation of Proprietary Drug Targets and Moves into Drug Discovery

MECHELEN, Belgium, June 7, 2004 (PRIMEZONE) -- Galapagos Genomics NV, Europe's leading target discovery company, announced today that it has identified, validated and filed patent applications on...
February 12, 2004 02:12 ET | Source: Galapagos Genomics

Galapagos Receives Grant for Alzheimer's Disease Research

MECHELEN, Belgium, Feb. 12, 2004 (PRIMEZONE) -- Galapagos Genomics, the Belgian functional genomics company, today announced that it has been awarded by the IWT (The Flemish Institute for the...
December 16, 2003 02:11 ET | Source: Galapagos Genomics

Bayer Healthcare and Galapagos in Target Discovery Collaboration

MECHELEN, Belgium, Dec. 16, 2003 (PRIMEZONE) -- Galapagos Genomics today announced a target discovery collaboration with Bayer HealthCare AG. Within the partnership, the Companies will collaborate to...
November 13, 2003 02:12 ET | Source: Galapagos Genomics

Wyeth Pharmaceuticals and Galapagos form Discovery Alliance in Osteoporosis

MECHELEN, Belgium, Nov. 13, 2003 (PRIMEZONE) -- Galapagos Genomics today announced that it has entered into a discovery alliance in the field of osteoporosis with Wyeth Pharmaceuticals, the...
November 11, 2003 02:13 ET | Source: Galapagos Genomics

Boehringer Ingelheim and Galapagos Genomics team up in antiviral discovery research program

MECHELEN, Belgium, Nov. 11, 2003 (PRIMEZONE) -- Boehringer Ingelheim and Galapagos Genomics have entered into a collaboration in the field of antiviral discovery research. Under the terms of this...
October 16, 2003 09:22 ET | Source: Galapagos Genomics

Galapagos reports adenoviral siRNA based results

MECHELEN, Belgium, Oct. 16, 2003 (PRIMEZONE) -- Galapagos Genomics today announced that it has published its adenoviral siRNA based gene silencing technology in the scientific journal Genome Research...
June 11, 2003 07:36 ET | Source: Galapagos Genomics

Galapagos Genomics and Procter & Gamble Collaborate in Osteoporosis

MECHELEN, Belgium, June 11, 2003 (PRIMEZONE) -- Galapagos Genomics, a privately held functional genomics company, today announced that it has entered into collaboration with Procter & Gamble...
May 13, 2003 07:37 ET | Source: Galapagos Genomics

Galapagos Genomics to Launch Full-Length Human Gene Adenoviral Expression Library

MECHELEN, Belgium, May 13, 2003 (PRIMEZONE) -- Galapagos Genomics, the Netherlands/Belgian functional genomics company, today announced the launch of their human full-length gene adenoviral...
April 29, 2003 07:51 ET | Source: Galapagos Genomics

Inpharmatica and Galapagos Genomics Enter Drug Discovery Collaboration

MECHELEN, Belgium, April 29, 2003 (PRIMEZONE) -- Inpharmatica Ltd. a leading informatics-driven drug discovery company, and Galapagos Genomics NV, the Belgian functional genomics company, today...